U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
HM-11260C
Preferred Name English
EFPEGLENATIDE
INN  
INN   USAN  
Official Name English
efpeglenatide [INN]
Common Name English
SAR-439977
Code English
EFPEGLENATIDE [USAN]
Common Name English
HM11260C
Code English
SAR439977
Code English
POLY(OXY-1,2-ETHANEDIYL), .ALPHA.-HYDRO-.OMEGA.-HYDROXY-, 26-ETHER WITH N-(2-(1H-IMIDAZOL-5-YL)ACETYL)GLYCYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-LEUCYL-L-SERYL-L-LYSYL-L-GLUTAMINYL-L-METHIONYL-L-.ALP
Common Name English
LANGLENATIDE
WHO-DD  
Common Name English
EXENATIDE DERIVATIVE AND HUMAN IGG4 FC DIMER LINKED TOGETHER WITH POLYETHYLENE GLYCOL DERIVATIVE: N 6.27 , N . 1'-(.OMEGA.-(OXYPROPANE-1,3-DIYL)-.ALPHA.-(PROPANE-1,3-DIYL)POLY(OXYETHYLENE)) (1-(IMIDAZOL-4-YLACETIC ACID))EXENDIN-4 HELODERMA SUSPECTUM (GIL
Systematic Name English
IMIDAZOACETYL-EXENDIN-4-PEG-IMMUNOGLOBULIN FC FRAGMENT CONJUGATE
Common Name English
Efpeglenatide [WHO-DD]
Common Name English
Code System Code Type Description
CAS
1454680-59-1
Created by admin on Mon Mar 31 21:51:22 GMT 2025 , Edited by admin on Mon Mar 31 21:51:22 GMT 2025
ALTERNATIVE
CAS
1296200-77-5
Created by admin on Mon Mar 31 21:51:22 GMT 2025 , Edited by admin on Mon Mar 31 21:51:22 GMT 2025
PRIMARY
DRUG BANK
DB15650
Created by admin on Mon Mar 31 21:51:22 GMT 2025 , Edited by admin on Mon Mar 31 21:51:22 GMT 2025
PRIMARY
USAN
HI-196
Created by admin on Mon Mar 31 21:51:22 GMT 2025 , Edited by admin on Mon Mar 31 21:51:22 GMT 2025
PRIMARY
INN
9580
Created by admin on Mon Mar 31 21:51:22 GMT 2025 , Edited by admin on Mon Mar 31 21:51:22 GMT 2025
PRIMARY
SMS_ID
100000180105
Created by admin on Mon Mar 31 21:51:22 GMT 2025 , Edited by admin on Mon Mar 31 21:51:22 GMT 2025
PRIMARY
FDA UNII
3M1V5Z2270
Created by admin on Mon Mar 31 21:51:22 GMT 2025 , Edited by admin on Mon Mar 31 21:51:22 GMT 2025
PRIMARY
NCI_THESAURUS
C166682
Created by admin on Mon Mar 31 21:51:22 GMT 2025 , Edited by admin on Mon Mar 31 21:51:22 GMT 2025
PRIMARY
ACTIVE MOIETY
EFPEGLENATIDE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966